YG
Gloor, Yvonne Sylvia
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Cytochrome P450 phenotyping using the Geneva cocktail improves metabolic capacity prediction in a hospitalized patient population | BJCP. British journal of clinical pharmacology |  | 2025 | 5 | 0 | ||
| Simulation-Based Optimization of Sampling Schedules for Model-Informed Precision Dosing of Once-Daily and 4-Times-Daily Busulfan in Pediatric Patients | Therapeutic drug monitoring |  | 2024 | 8 | 5 | ||
| Microcavity-assisted cloning (MAC) of hard-to-clone HepG2 cell lines : cloning made easy | BMC biotechnology | | 2024 | 16 | 13 | ||
| Evaluation of important human CYP450 isoforms and P-glycoprotein phenotype changes and genotype in type 2 diabetic patients, before and after intensifying treatment regimen using Geneva cocktail | Basic & clinical pharmacology & toxicology | | 2023 | 114 | 0 | ||
| Impact of obesity and bariatric surgery on metabolic enzymes and p-glycoprotein activity using the Geneva cocktail approach | Journal of personalized medicine | | 2023 | 88 | 20 | ||
| Uncovering a Genetic Polymorphism Located in Huntingtin Associated Protein 1 in Modulation of Central Pain Sensitization Signaling Pathways | Frontiers in neuroscience | | 2022 | 416 | 75 | ||
| Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting | Journal of personalized medicine | | 2022 | 221 | 203 | ||
| Genetic Susceptibility Toward Nausea and Vomiting in Surgical Patients | Frontiers in genetics | | 2022 | 239 | 138 | ||
| Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P-Glycoprotein Activities | Clinical pharmacology & therapeutics | | 2022 | 174 | 333 | ||
| Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail | Clinical pharmacology and therapeutics | | 2021 | 206 | 127 | ||
| Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity | British journal of pharmacology | | 2021 | 321 | 134 | ||
| Reviewing Data Integrated for PBPK Model Development to Predict Metabolic Drug-Drug Interactions: Shifting Perspectives and Emerging Trends | Frontiers in pharmacology | | 2021 | 181 | 183 | ||
| Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva Cocktail | Clinical Pharmacology and Therapeutics | | 2020 | 330 | 439 | ||
| Cytochrome P450 1A2 activity and incidence of thyroid disease and cancer after chronic or acute exposure to dioxins | Basic & Clinical Pharmacology & Toxicology | | 2019 | 466 | 4 | ||
| Early biomarker discovery of paracetamol-induced hepato-toxicity after therapeutic doses: experimental tool implementation | | 2017 | 103 | 1 |
